Decreased expression of p39 is associated with a poor prognosis in human hepatocellular carcinoma

Medical Oncology

Volumn 28, Issue SUPPL. 1, 2011, Pages

  Lu, Jeng Wei ^a   Chang, Jan Gowth ^b   Yeh, Kun Tu ^c   Chen, Rong Ming ^e   Tsai, Jeffrey J P ^a   Hu, Rouh Mei ^a,d  

^a ASIA UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e NATIONAL UNIVERSITY OF TAINAN   (Taiwan)

Author keywords

CDK5R2; Human hepatocellular carcinoma; Immunohistochemistry; p39; Prognosis

Indexed keywords

PROTEIN P39;

ADULT; ARTICLE; CANCER PATIENT; CANCER TISSUE; CLINICAL FEATURE; COMPARATIVE STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL RATE;

EID: 84655176740     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9707-9     Document Type: Article

References (51)

1. JL Sung 1984 Hepatitis B virus infection and its sequelae in Taiwan Gastroenterol Jpn 4 363 366
2. HB El-Serag KL Rudolph 2007 Hepatocellular carcinoma: epidemiology and molecular carcinogenesis Gastroenterology 7 2557 2576 (Pubitemid 46890874)
3. CR Marrero JA Marrero 2007 Viral hepatitis and hepatocellular carcinoma Arch Med Res 6 612 620 (Pubitemid 47001566)
4. KA [tmp] McGlynn WT London 2005 Epidemiology and natural history of hepatocellular carcinoma Best Practice Res 1 3 23 (Pubitemid 40331495)
5. TR Morgan S Mandayam MM Jamal 2004 Alcohol and hepatocellular carcinoma Gastroenterology 5 87 96
6. LB Seeff JH Hoofnagle 2006 Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity Oncogene 27 3771 3777 (Pubitemid 43980472)
7. TY Lin CS Lee KM Chen CC Chen 1987 Role of surgery in the treatment of primary carcinoma of the liver: a 31-year experience Br J Surg 9 839 842
8. HB El-Serag AC Mason C Key 2001 Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States Hepatology 1 62 65 (Pubitemid 32016888)
9. FX Bosch J Ribes J Borras 1999 Epidemiology of primary liver cancer Semin Liver Dis 3 271 285 (Pubitemid 29488770)
10. E Mor RT Kaspa P Sheiner M Schwartz 1998 Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation Ann Intern Med 8 643 653 (Pubitemid 28480821)
11. V Lalioti D Pulido IV Sandoval 2010 Cdk5, the multifunctional surveyor Cell Cycle 9 284 311
12. FA Dhariwala MS Rajadhyaksha 2008 An unusual member of the Cdk family: Cdk5 Cell Mol Neurobiol 3 351 369
13. JL Rosales KY Lee 2006 Extraneuronal roles of cyclin-dependent kinase 5 Bioessays 10 1023 1034 (Pubitemid 44570451)
14. G Paglini A Caceres 2001 The role of the Cdk5-p35 kinase in neuronal development Eur J Biochem 6 1528 1533 (Pubitemid 32862684)
15. D Tang J Yeung KY Lee M Matsushita H Matsui K Tomizawa 1995 An isoform of the neuronal cyclin-dependent kinase 5 (Cdk5) activator J Biol Chem 45 26897 26903
16. S Hisanaga T Saito 2003 The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator Neurosignals 4 221 229 (Pubitemid 37548237)
17. J Ko S Humbert RT Bronson S Takahashi AB Kulkarni E Li 2001 p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment J Neurosci 17 6758 6771 (Pubitemid 32781119)
18. LH Tsai T Takahashi VS Caviness Jr E Harlow 1993 Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system Development 4 1029 1040 (Pubitemid 23358574)
19. JB Lazaro M Kitzmann MA Poul M Vandromme NJ Lamb A Fernandez 1997 Cyclin dependent kinase 5, cdk5, is a positive regulator of myogenesis in mouse C2 cells J Cell Sci 10 1251 1260 (Pubitemid 27254399)
20. CY Gao Z Zakeri Y Zhu H He PS Zelenka 1997 Expression of Cdk5, p35, and Cdk5-associated kinase activity in the developing rat lens Dev Genet 3 267 275 (Pubitemid 27284088)
21. DR Session MP Fautsch R Avula WR Jones A Nehra ED Wieben 2001 Cyclin-dependent kinase 5 is expressed in both Sertoli cells and metaphase spermatocytes Fertil Steril 4 669 673 (Pubitemid 32273500)
22. F Chen GP Studzinski 2001 Expression of the neuronal cyclin-dependent kinase 5 activator p35Nck5a in human monocytic cells is associated with differentiation Blood 12 3763 3767
23. L Lilja SN Yang DL Webb L Juntti-Berggren PO Berggren C Bark 2001 Cyclin-dependent kinase 5 promotes insulin exocytosis J Biol Chem 36 34199 34205
24. D Mao PW Hinds 2010 p35 is required for CDK5 activation in cellular senescence J Biol Chem 19 14671 14680
25. B Tian Q Yang Z Mao 2009 Phosphorylation of ATM by Cdk5 mediates DNA damage signalling and regulates neuronal death Nat Cell Biol 2 211 218
26. K Alexander HS Yang PW Hinds 2004 Cellular senescence requires CDK5 repression of Rac1 activity Mol Cell Biol 7 2808 2819 (Pubitemid 38386635)
27. HS Yang K Alexander P Santiago PW Hinds 2003 ERM proteins and Cdk5 in cellular senescence Cell Cycle 6 517 520
28. HS Kuo FN Hsu MC Chiang SC You MC Chen MJ Lo 2009 The role of Cdk5 in retinoic acid-induced apoptosis of cervical cancer cell line Chin J Physiol 1 23 30
29. H Lin JL Juang PS Wang 2004 Involvement of Cdk5/p25 in digoxin-triggered prostate cancer cell apoptosis J Biol Chem 28 29302 29307 (Pubitemid 38915807)
30. T Sandal C Stapnes H Kleivdal L Hedin SO Doskeland 2002 A novel, extraneuronal role for cyclin-dependent protein kinase 5 (CDK5): modulation of cAMP-induced apoptosis in rat leukemia cells J Biol Chem 23 20783 20793 (Pubitemid 34967384)
31. CY Gao MA Stepp R Fariss P Zelenka 2004 Cdk5 regulates activation and localization of Src during corneal epithelial wound closure J Cell Sci 117 4089 4098 (Pubitemid 39328297)
32. TK Pareek AB Kulkarni 2006 Cdk5: a new player in pain signaling Cell Cycle 6 585 588
33. H Lin MC Chen CY Chiu YM Song SY Lin 2007 Cdk5 regulates STAT3 activation and cell proliferation in medullary thyroid carcinoma cells J Biol Chem 5 2776 2784 (Pubitemid 47084342)
34. G Feldmann A Mishra SM Hong S Bisht CJ Strock DW Ball 2010 Inhibiting the cyclin-dependent kinase CDK5 blocks pancreatic cancer formation and progression through the suppression of Ras-Ral signaling Cancer Res 11 4460 4469
35. CJ Strock JI Park EK Nakakura GS Bova JT Isaacs DW Ball 2006 Cyclin-dependent kinase 5 activity controls cell motility and metastatic potential of prostate cancer cells Cancer Res 15 7509 7515 (Pubitemid 44289205)
36. JL Liu XY Wang BX Huang F Zhu RG Zhang G Wu 2010 Expression of CDK5/p35 in resected patients with non-small cell lung cancer: relation to prognosis Med Oncol 10 9510 9517
37. M Yamada T Saito Y Sato Y Kawai A Sekigawa Y Hamazumi 2007 Cdk5-p39 is a labile complex with the similar substrate specificity to Cdk5-p35 J Neurochem 5 1477 1487 (Pubitemid 47256187)
38. X Chen ST Cheung S So ST Fan C Barry J Higgins 2002 Gene expression patterns in human liver cancers Mol Biol Cell 6 1929 1939 (Pubitemid 34651483)
39. S Hirohashi KG Ishak M Kojiro PL Puig IR Wanless HP Fischer ND Theise M Sakamoto H Tsukuma 2000
40. P Lippincott-Raven 2009
41. KT Yeh MY Yang TC Liu JC Chen WL Chan SF Lin 2005 Abnormal expression of period 1 (PER1) in endometrial carcinoma J Pathol 1 111 120
42. TD Schmittgen KJ Livak 2008 Analyzing real-time PCR data by the comparative C(T) method Nat Protoc 6 1101 1108 (Pubitemid 351818697)
43. HH Tseng YH Hwang KT Yeh JG Chang YL Chen HS Yu 2009 Reduced expression of C/EBP alpha protein in hepatocellular carcinoma is associated with advanced tumor stage and shortened patient survival J Cancer Res Clin Oncol 2 241 247
44. N Mantel 1966 Evaluation of survival data and two new rank order statistics arising in its consideration Cancer Chemother Rep 3 163 170
45. DC Wu YP Yu NT Lee AC Yu JH Wang YF Han 2000 The expression of Cdk5, p35, p39, and Cdk5 kinase activity in developing, adult, and aged rat brains Neurochem Res 7 923 929 (Pubitemid 30636991)
46. S Humbert R Dhavan L Tsai 2000 p39 activates cdk5 in neurons, and is associated with the actin cytoskeleton J Cell Sci 6 975 983 (Pubitemid 30179477)
47. DR Ledee BK Tripathi PS Zelenka 2007 The CDK5 activator, p39, binds specifically to myosin essential light chain Biochem Biophys Res Commun 4 1034 1039 (Pubitemid 46223554)
48. DR Ledee CY Gao R Seth RN Fariss BK Tripathi PS Zelenka 2005 A specific interaction between muskelin and the cyclin-dependent kinase 5 activator p39 promotes peripheral localization of muskelin J Biol Chem 22 21376 21383 (Pubitemid 40805701)
49. AK Ajay AK Upadhyay S Singh MV Vijayakumar R Kumari V Pandey 2010 Cdk5 phosphorylates non-genotoxically overexpressed p53 following inhibition of PP2A to induce cell cycle arrest/apoptosis and inhibits tumor progression Mol Cancer 9 204 219
50. J Zhang PK Krishnamurthy GV Johnson 2002 Cdk5 phosphorylates p53 and regulates its activity J Neurochem 2 307 313 (Pubitemid 34809356)
51. JH Lee MW Jeong W Kim YH Choi KT Kim 2008 Cooperative roles of c-Abl and Cdk5 in regulation of p53 in response to oxidative stress J Biol Chem 28 19826 19835